UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Identification of the First Synthetic Steroidogenic Factor 1 Inverse Agonists: Pharmacological Modulation of Steroidogenic Enzymes

Molecular pharmacology, 2008-03, Vol.73 (3), p.900-908

2008

Link zum Volltext

Verfügbarkeit prüfen

Oral RKS262 reduces tumor burden in a neuroblastoma xenograft animal model and mediates cytotoxicity through SAPK/JNK and ROS activation in vitro

Cancer biology & therapy, 2011-06, Vol.11 (12), p.1036-1045

2011

Link zum Volltext

Verfügbarkeit prüfen

Optimization of isochromanone based urotensin II receptor agonists

Bioorganic & medicinal chemistry, 2010-07, Vol.18 (13), p.4844-4854

2010

Link zum Volltext

Verfügbarkeit prüfen

Identification of novel subtype selective RAR agonists

Biochemical pharmacology, 2005-12, Vol.71 (1), p.156-162

2005

Link zum Volltext

Verfügbarkeit prüfen

Identification of the Atypical L-Type Ca2+ Channel Blocker Diltiazem and Its Metabolites As Ghrelin Receptor Agonists

Molecular pharmacology, 2007-08, Vol.72 (2), p.380-386

2007

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Potent and Selective Small-Molecule PAR-2 Agonists

Journal of medicinal chemistry, 2008-09, Vol.51 (18), p.5490-5493

2008

Link zum Volltext

Verfügbarkeit prüfen

Design, parallel synthesis and SAR of novel urotensin II receptor agonists

European journal of medicinal chemistry, 2007-02, Vol.42 (2), p.276-285

2007

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Evaluation of Dibenzothiazepines: A Novel Class of Selective Cannabinoid-1 Receptor Inverse Agonists

Journal of medicinal chemistry, 2009-04, Vol.52 (7), p.1975-1982

2009

Link zum Volltext

Verfügbarkeit prüfen

Discovery of non-peptidergic MrgX1 and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis

Bioorganic & medicinal chemistry letters, 2009-03, Vol.19 (6), p.1729-1732

2009

Link zum Volltext

Verfügbarkeit prüfen

Novel Potent and Efficacious Nonpeptidic Urotensin II Receptor Agonists

Journal of medicinal chemistry, 2006-04, Vol.49 (7), p.2232-2240

2006

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a class of calcium sensing receptor positive allosteric modulators; 1-(benzothiazol-2-yl)-1-phenylethanols

Bioorganic & medicinal chemistry letters, 2010-10, Vol.20 (19), p.5918-5921

2010

Link zum Volltext

Verfügbarkeit prüfen

Novel and potent small-molecule urotensin II receptor agonists

Bioorganic & medicinal chemistry, 2009-07, Vol.17 (13), p.4657-4665

2009

Link zum Volltext

Verfügbarkeit prüfen

Isochromanone-based urotensin-II receptor agonists

Bioorganic & medicinal chemistry, 2005-04, Vol.13 (8), p.3057-3068

2005

Link zum Volltext

Verfügbarkeit prüfen

Integrative functional assays, chemical genomics and high throughput screening: harnessing signal transduction pathways to a common HTS readout

Current pharmaceutical design, 2006-05, Vol.12 (14), p.1717

2006

Link zum Volltext

Verfügbarkeit prüfen

Discovery of the First Nonpeptide Agonist of the GPR14/Urotensin-II Receptor: 3-(4-Chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954)

Journal of medicinal chemistry, 2002-11, Vol.45 (23), p.4950-4953

2002

Link zum Volltext

Verfügbarkeit prüfen

Identification of novel selective v2 receptor non-peptide agonists

Biochemical pharmacology, 2008-10, Vol.76 (9), p.1134-1141

2008

Link zum Volltext

Verfügbarkeit prüfen

Discovery of novel peptide/receptor interactions: identification of PHM-27 as a potent agonist of the human calcitonin receptor

Biochemical pharmacology, 2004-04, Vol.67 (7), p.1279-1284

2004

Link zum Volltext

Verfügbarkeit prüfen

The ras-related GTPase rac1 regulates a proliferative pathway selectively utilized by G-protein coupled receptors

Oncogene, 1998-09, Vol.17 (12), p.1617-1623

1998

Link zum Volltext

Verfügbarkeit prüfen

Discovery of an Ectopic Activation Site on the M 1 Muscarinic Receptor

Molecular pharmacology, 2002-06, Vol.61 (6), p.1297-1302

2002

Link zum Volltext

Verfügbarkeit prüfen

A study to investigate the significance of knowing ones' prognosis in people diagnosed with life-limiting illnesses

Currier, Erika A

2015

Link zum Volltext
ProQuest

Abstract 5260: Bortezomib and HDAC inhibitor PCI-24781 combination therapy for neuroblastoma

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.5260-5260

2010

Link zum Volltext

Verfügbarkeit prüfen

Discovery of non-peptidergic MrgXl and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis

Bioorganic & medicinal chemistry letters, 2009, Vol.19 (6), p.1729-1732

2009

Link zum Volltext

Verfügbarkeit prüfen

Identification of novel selective V 2 receptor non-peptide agonists

Biochemical pharmacology, 2008, Vol.76 (9), p.1134-1141

2008

Link zum Volltext

Verfügbarkeit prüfen

Identification of the Atypical L-Type Ca super(2+) Channel Blocker Diltiazem and Its Metabolites As Ghrelin Receptor Agonists

Molecular pharmacology, 2007-08, Vol.72 (2), p.380-386

2007

Link zum Volltext

Verfügbarkeit prüfen

Identification of the Atypical L-Type Ca 2+ Channel Blocker Diltiazem and Its Metabolites As Ghrelin Receptor Agonists

Molecular pharmacology, 2007-08, Vol.72 (2), p.380-386

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(39)
Dissertationen
(1)

Sprache

Englisch
(40)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(21)
Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Animals
(19)
Pharmacology & Pharmacy
(17)
Biological And Medical Sciences
(15)
Mice
(15)
Medical Sciences
(14)
Pharmacology. Drug Treatments
(14)
Structure-Activity Relationship
(11)
Chemistry, Medicinal
(10)
Neuropharmacology
(8)
Neurotransmitters. Neurotransmission. Receptors
(8)
Models, Molecular
(7)
Receptors, G-Protein-Coupled - Agonists
(7)
Nih 3t3 Cells
(6)
Rats
(6)
Biochemistry & Molecular Biology
(5)
Chemistry
(5)
Chemistry, Organic
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification of the First Synthetic Steroidogenic Factor 1 Inverse Agonists: Pharmacological Modulation of Steroidogenic Enzymes

Oral RKS262 reduces tumor burden in a neuroblastoma xenograft animal model and mediates cytotoxicity through SAPK/JNK and ROS activation in vitro

Optimization of isochromanone based urotensin II receptor agonists

Identification of novel subtype selective RAR agonists

Identification of the Atypical L-Type Ca2+ Channel Blocker Diltiazem and Its Metabolites As Ghrelin Receptor Agonists

Discovery of Potent and Selective Small-Molecule PAR-2 Agonists

Design, parallel synthesis and SAR of novel urotensin II receptor agonists

Synthesis and Evaluation of Dibenzothiazepines: A Novel Class of Selective Cannabinoid-1 Receptor Inverse Agonists

Discovery of non-peptidergic MrgX1 and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis

Novel Potent and Efficacious Nonpeptidic Urotensin II Receptor Agonists

Discovery of a class of calcium sensing receptor positive allosteric modulators; 1-(benzothiazol-2-yl)-1-phenylethanols

Novel and potent small-molecule urotensin II receptor agonists

Isochromanone-based urotensin-II receptor agonists

Integrative functional assays, chemical genomics and high throughput screening: harnessing signal transduction pathways to a common HTS readout

Discovery of the First Nonpeptide Agonist of the GPR14/Urotensin-II Receptor: 3-(4-Chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954)

Identification of novel selective v2 receptor non-peptide agonists

Discovery of novel peptide/receptor interactions: identification of PHM-27 as a potent agonist of the human calcitonin receptor

The ras-related GTPase rac1 regulates a proliferative pathway selectively utilized by G-protein coupled receptors

Discovery of an Ectopic Activation Site on the M 1 Muscarinic Receptor

A study to investigate the significance of knowing ones' prognosis in people diagnosed with life-limiting illnesses

Abstract 5260: Bortezomib and HDAC inhibitor PCI-24781 combination therapy for neuroblastoma

Discovery of non-peptidergic MrgXl and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis

Identification of novel selective V 2 receptor non-peptide agonists

Identification of the Atypical L-Type Ca super(2+) Channel Blocker Diltiazem and Its Metabolites As Ghrelin Receptor Agonists

Identification of the Atypical L-Type Ca 2+ Channel Blocker Diltiazem and Its Metabolites As Ghrelin Receptor Agonists

Suchergebnisse filtern